PDGFRB, platelet‐derived growth factor receptor beta, has some evidence linking DNA damage in gliomas (Squatrito & Holland, 2011) and fibrosarcoma models (Medová, Aebersold, & Zimmer, 2013). Here, PDGFRB is linked to central nervous system cancer.